Skip to content

Similar papers

Open access Sep 2026

NONO modulates tumorigenesis and metastatic potential of lung squamous cell carcinoma

Lung squamous cell carcinoma (LUSC) is associated with limited therapeutic options and poor clinical prognosis. The Octamer nucleotide--binding transcription factor (NONO), which lacks the POU domain, is implicated in nearly every aspect of gene regulation. It participates in various biological processes including cell...

Jin-Long Huang, Li-Ping Zhu, Wei-Qing Zhang et al. · 0 citations
Open access Sep 2026

Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling

Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality worldwide, and current targeted therapeutic options remain inadequate. Gilteritinib, a clinically approved tyrosine kinase inhibitor, has shown antitumor activity in hematologic malignancies; however, its therapeutic...

Si-Jing Chen, Yun-Yang Zhao, Yun-Qi Pan et al. · 0 citations
Sep 2026

Syntaxin 1 A knockdown suppresses hepatocellular carcinoma cell viability and invasion but induces apoptosis primarily through the AKT pathway.

OBJECTIVE Syntaxin 1 A (STX1A) was recently shown to regulate the progression of several cancers. However, the role of STX1A in hepatocellular carcinoma (HCC) remains unclear. We examined how STX1A affects HCC cell behavior and its relationship to the AKT and ERK pathways. METHODS The clinical implications of STX1A i...

Jun-Duo Hu, Guo-An Gao, Ying-Li Zhou et al. · 0 citations
Open access

Molecular functional evaluation of novel c-myc targeting anticancer compounds in non-small cell lung cancer and colon cancer cells

The c-Myc protein is a key regulator of cell growth, proliferation, and differentiation. Its overexpression or dysregulation is linked to several cancers, including non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). Here, we described ECD, a novel small molecule targeting c-Myc, which disrupts the c-Myc/MA...

Nicharat Sriratanasak · 0 citations
Open access Sep 2026

EAG1 channel is a central regulator of tumor growth and metastasis in A549 non-small cell lung cancer cells.

It is demonstrated that loss of EAG1 markedly suppresses tumor growth and metastasis of A549 NSCLC cells using a combination of tissue culture, xenograft and multi-omics approaches, highlighting EAG1 as a potential therapeutic target in NSCLC.

Joos Berghausen, Emre Deniz, Ze-Jun Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.